These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 12351814)
21. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors. Lansdorp PM; Dragowska W Exp Hematol; 1993 Sep; 21(10):1321-7. PubMed ID: 7689481 [TBL] [Abstract][Full Text] [Related]
22. Retroviral-mediated transduction of the fanconi anemia C complementing (FACC) gene in two murine transplantation models. Liu JM; Kim S; Walsh CE Blood Cells Mol Dis; 1995; 21(1):56-63. PubMed ID: 7544677 [TBL] [Abstract][Full Text] [Related]
23. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation. Zanier R; Briot D; Dugas du Villard JA; Sarasin A; Rosselli F Oncogene; 2004 Jun; 23(29):5004-13. PubMed ID: 15077170 [TBL] [Abstract][Full Text] [Related]
24. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Cumming RC; Lightfoot J; Beard K; Youssoufian H; O'Brien PJ; Buchwald M Nat Med; 2001 Jul; 7(7):814-20. PubMed ID: 11433346 [TBL] [Abstract][Full Text] [Related]
25. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885 [TBL] [Abstract][Full Text] [Related]
27. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells. Umland O; Heine H; Miehe M; Marienfeld K; Staubach KH; Ulmer AJ J Leukoc Biol; 2004 Apr; 75(4):671-9. PubMed ID: 14742640 [TBL] [Abstract][Full Text] [Related]
28. The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels. D'Atri LP; Etulain J; Romaniuk MA; Torres O; Negrotto S; Schattner M Transfusion; 2011 Aug; 51(8):1784-95. PubMed ID: 21332728 [TBL] [Abstract][Full Text] [Related]
29. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460 [TBL] [Abstract][Full Text] [Related]
30. Cytokine-augmented culture of haematopoietic progenitor cells in a novel three-dimensional cell growth matrix. Banu N; Rosenzweig M; Kim H; Bagley J; Pykett M Cytokine; 2001 Mar; 13(6):349-58. PubMed ID: 11292318 [TBL] [Abstract][Full Text] [Related]
31. FANCE: the link between Fanconi anaemia complex assembly and activity. Pace P; Johnson M; Tan WM; Mosedale G; Sng C; Hoatlin M; de Winter J; Joenje H; Gergely F; Patel KJ EMBO J; 2002 Jul; 21(13):3414-23. PubMed ID: 12093742 [TBL] [Abstract][Full Text] [Related]
32. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex. Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664 [TBL] [Abstract][Full Text] [Related]
33. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation. Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278 [TBL] [Abstract][Full Text] [Related]
34. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation. Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303 [TBL] [Abstract][Full Text] [Related]
35. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice. Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381 [TBL] [Abstract][Full Text] [Related]
36. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C. Noll M; Bateman RL; D'Andrea AD; Grompe M Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306 [TBL] [Abstract][Full Text] [Related]
37. [Molecular basis of Fanconi's anemia]. Digweed M Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548 [TBL] [Abstract][Full Text] [Related]
38. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells. Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834 [TBL] [Abstract][Full Text] [Related]
39. Comparative study of the in vitro behavior of cord blood subpopulations after short-term cytokine exposure. Rice A; Flemming C; Case J; Stevenson J; Gaudry L; Vowels M Bone Marrow Transplant; 1999 Feb; 23(3):211-20. PubMed ID: 10084251 [TBL] [Abstract][Full Text] [Related]
40. Induction of c-kit molecules on human CD34+/c-kit < low cells: evidence for CD34+/c-kit < low cells as primitive hematopoietic stem cells. Sogo S; Inaba M; Ogata H; Hisha H; Adachi Y; Mori S; Toki J; Yamanishi K; Kanzaki H; Adachi M; Ikehara S Stem Cells; 1997; 15(6):420-9. PubMed ID: 9402654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]